Kura Oncology’s Conference Calendar: Three Exciting Investor Events Ahead!

Kura Oncology’s CEO, Troy Wilson, to Speak at Three Upcoming Investor Conferences SAN DIEGO, Feb. 25, 2025 – Kura Oncology, a pioneering biopharmaceutical company dedicated to the development of precision medicines for cancer treatment, announced today that its President and CEO, Troy Wilson, Ph.D., J.D., will attend and participate in three upcoming investor conferences. Conferences…

Read More

Class Action Suit Surprises Innovative Industrial Properties, Inc. (IWP): A Curious Turn in Business News

Curious Human: “Hey AI, I’ve been following Innovative Industrial Properties, Inc. (IIPR) and I’ve taken a hit on my investments. What can I do about it under the federal securities laws?” Artificial Intelligence Assistant: “I’m sorry to hear about your losses, human friend! Let’s see if we can’t help you navigate this situation. If you…

Read More

InflaRx Announces Full-Year 2024 Results Release Date and Upcoming Investor Conference Participation

InflaRx Announces Release Date for Fourth Quarter and Full Year 2024 Financial Results JENA, Germany, Feb. 25, 2025 – InflaRx N.V., a pioneering biopharmaceutical company specializing in anti-inflammatory therapeutics through the targeting of the complement system, has announced that it will release its financial and operating results for the fourth quarter and full year ending…

Read More

Levi and Korsinsky Urge Atkore Investors: Don’t Forget About Pending Class Action Lawsuit (CL 991138)

Understanding the Atkore Inc. Lawsuit: Implications for Investors and the World In the bustling financial landscape of New York City, the securities world was abuzz with the latest development concerning Atkore Inc. (ATKR), a leading manufacturer of electrical and mechanical products. On February 25, 2025, a press release was disseminated through ACCESS Newswire, announcing that…

Read More